Anti- HIV-1 activity of lactic acid in human cervicovaginal fluid
Version 3 2024-06-20, 00:09Version 3 2024-06-20, 00:09
Version 2 2024-06-03, 03:23Version 2 2024-06-03, 03:23
Version 1 2024-03-13, 01:13Version 1 2024-03-13, 01:13
journal contribution
posted on 2024-06-20, 00:09authored byD Tyssen, YY Wang, JA Hayward, Paul AgiusPaul Agius, K DeLong, M Aldunate, J Ravel, TR Moench, RA Cone, G Tachedjiana
The
Lactobacillus
-dominated vaginal microbiota is associated with a reduced risk of acquiring and transmitting HIV and other sexually transmitted infections (STIs). Lactic acid is a major organic acid metabolite produced by lactobacilli that acidifies the vagina and has been reported to have inhibitory activity
in vitro
against bacterial, protozoan, and viral STIs, including HIV infections. However, the anti-HIV properties of lactic acid in native vaginal lumen fluids of women colonized with
Lactobacillus
spp. have not yet been established. Our study, using native cervicovaginal fluid from women, found that potent and irreversible anti-HIV-1 activity is significantly associated with the concentration of the protonated (acidic, uncharged) form of lactic acid. This work advances our understanding of the mechanisms by which vaginal microbiota modulate HIV susceptibility and could lead to novel strategies to prevent women from acquiring HIV or transmitting the virus during vaginal intercourse and vaginal birth.